Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 181

1.

Reduced renal function is associated with progression to AIDS but not with overall mortality in HIV-infected Kenyan adults not initially requiring combination antiretroviral therapy.

Gupta SK, Ong'or WO, Shen C, Musick B, Goldman M, Wools-Kaloustian K.

J Int AIDS Soc. 2011 Jun 11;14:31. doi: 10.1186/1758-2652-14-31.

PMID:
21663693
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment.

Braitstein P, Siika A, Hogan J, Kosgei R, Sang E, Sidle J, Wools-Kaloustian K, Keter A, Mamlin J, Kimaiyo S.

J Int AIDS Soc. 2012 Feb 17;15(1):7. doi: 10.1186/1758-2652-15-7.

PMID:
22340703
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Determinants of antiretroviral therapy initiation and treatment outcomes for people living with HIV in Vietnam.

Tran DA, Shakeshaft A, Ngo AD, Mallitt KA, Wilson D, Doran C, Zhang L.

HIV Clin Trials. 2013 Jan-Feb;14(1):21-33. doi: 10.1410/hct1401-21.

PMID:
23372112
[PubMed - indexed for MEDLINE]
4.

Effectiveness of early antiretroviral therapy initiation to improve survival among HIV-infected adults with tuberculosis: a retrospective cohort study.

Franke MF, Robins JM, Mugabo J, Kaigamba F, Cain LE, Fleming JG, Murray MB.

PLoS Med. 2011 May;8(5):e1001029. doi: 10.1371/journal.pmed.1001029. Epub 2011 May 3.

PMID:
21559327
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition.

Mossdorf E, Stoeckle M, Mwaigomole EG, Chiweka E, Kibatala PL, Geubbels E, Urassa H, Abdulla S, Elzi L, Tanner M, Furrer H, Hatz C, Battegay M.

BMC Infect Dis. 2011 Apr 19;11:98. doi: 10.1186/1471-2334-11-98.

PMID:
21504595
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.

HIV-CAUSAL Collaboration, Cain LE, Logan R, Robins JM, Sterne JA, Sabin C, Bansi L, Justice A, Goulet J, van Sighem A, de Wolf F, Bucher HC, von Wyl V, Esteve A, Casabona J, del Amo J, Moreno S, Seng R, Meyer L, Perez-Hoyos S, Muga R, Lodi S, Lanoy E, Costagliola D, Hernan MA.

Ann Intern Med. 2011 Apr 19;154(8):509-15. doi: 10.7326/0003-4819-154-8-201104190-00001.

PMID:
21502648
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.

Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS.

Antivir Ther. 2003 Oct;8(5):379-84.

PMID:
14640384
[PubMed - indexed for MEDLINE]
8.

Prevalence of low estimated glomerular filtration rate, proteinuria, and associated risk factors among HIV-infected black patients using Cockroft-Gault and modification of diet in renal disease study equations.

Longo AL, Lepira FB, Sumaili EK, Makulo JR, Mukumbi H, Bukabau JB, Mokoli VM, Kayembe PK, Nseka NM.

J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):59-64. doi: 10.1097/QAI.0b013e31823587b0.

PMID:
21926635
[PubMed - indexed for MEDLINE]
9.

Predictors of mortality among HIV-infected women in Kigali, Rwanda.

Lindan CP, Allen S, Serufilira A, Lifson AR, Van de Perre P, Chen-Rundle A, Batungwanayo J, Nsengumuremyi F, Bogaerts J, Hulley S.

Ann Intern Med. 1992 Feb 15;116(4):320-8.

PMID:
1733389
[PubMed - indexed for MEDLINE]
10.

Risk of all-cause mortality in HIV infected patients is associated with clinical, immunologic predictors and the CCR5 Δ32 deletion.

Parczewski M, Bander D, Leszczyszyn-Pynka M, Urbanska A, Kaczmarczyk M, Ciechanowicz A, Boron-Kaczmarska A.

PLoS One. 2011;6(7):e22215. doi: 10.1371/journal.pone.0022215. Epub 2011 Jul 18.

PMID:
21789236
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.

Holkmann Olsen C, Mocroft A, Kirk O, Vella S, Blaxhult A, Clumeck N, Fisher M, Katlama C, Phillips AN, Lundgren JD; EuroSIDA study group.

HIV Med. 2007 Mar;8(2):96-104.

PMID:
17352766
[PubMed - indexed for MEDLINE]
12.

The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.

Murray M, Hogg RS, Lima VD, May MT, Moore DM, Abgrall S, Bruyand M, D'Arminio Monforte A, Tural C, Gill MJ, Harris RJ, Reiss P, Justice A, Kirk O, Saag M, Smith CJ, Weber R, Rockstroh J, Khaykin P, Sterne JA; Antiretroviral Therapy Cohort Collaboration (ART-CC).

HIV Med. 2012 Feb;13(2):89-97. doi: 10.1111/j.1468-1293.2011.00940.x. Epub 2011 Aug 7.

PMID:
21819529
[PubMed - indexed for MEDLINE]
13.

Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study.

Miller V, Mocroft A, Reiss P, Katlama C, Papadopoulos AI, Katzenstein T, van Lunzen J, Antunes F, Phillips AN, Lundgren JD.

Ann Intern Med. 1999 Apr 6;130(7):570-7.

PMID:
10189326
[PubMed - indexed for MEDLINE]
14.

The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.

Estrella MM, Parekh RS, Abraham A, Astor BC, Szczech LA, Anastos K, Dehovitz JA, Merenstein DJ, Pearce CL, Tien PC, Cohen MH, Gange SJ.

J Acquir Immune Defic Syndr. 2010 Oct;55(2):217-20. doi: 10.1097/QAI.0b013e3181e674f4.

PMID:
20581688
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.

Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth JC, van Sighem A, Kirk O, Obel N, Panos G, Ghosn J, Dabis F, Mary-Krause M, Leport C, Perez-Hoyos S, Sobrino-Vegas P, Stephan C, Castagna A, Antinori A, d'Arminio Monforte A, Torti C, Mussini C, Isern V, Calmy A, Teira R, Egger M, Grarup J, Chêne G.

Int J Epidemiol. 2012 Apr;41(2):433-45. doi: 10.1093/ije/dyr164. Epub 2011 Nov 28.

PMID:
22493325
[PubMed - indexed for MEDLINE]
Free Article
16.

Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care.

Ganesan A, Krantz EM, Huppler Hullsiek K, Riddle MS, Weintrob AC, Lalani T, Okulicz JF, Landrum M, Agan B, Whitman TJ, Ross MJ, Crum-Cianflone NF; Infectious Disease Clinical Research Program HIV/STI Working Group.

HIV Med. 2013 Feb;14(2):65-76. doi: 10.1111/j.1468-1293.2012.01036.x. Epub 2012 Jul 19.

PMID:
22808988
[PubMed - indexed for MEDLINE]
17.

Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?

Rancinan C, Neau D, Savès M, Lawson-Ayayi S, Bonnet F, Mercié P, Dupon M, Couzigou P, Dabis F, Chêne G; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

AIDS. 2002 Jul 5;16(10):1357-62.

PMID:
12131212
[PubMed - indexed for MEDLINE]
18.

Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.

Hogg RS, Yip B, Kully C, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS.

CMAJ. 1999 Mar 9;160(5):659-65.

PMID:
10102000
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Factors associated with decreased kidney function in HIV-infected adults enrolled in the MTCT-Plus Initiative in sub-Saharan Africa.

Jao J, Lo W, Toro PL, Wyatt C, Palmer D, Abrams EJ, Carter RJ; MTCT-Plus Initiative.

J Acquir Immune Defic Syndr. 2011 May 1;57(1):40-5. doi: 10.1097/QAI.0b013e31821008eb.

PMID:
21266908
[PubMed - indexed for MEDLINE]
20.

Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.

Wolbers M, Babiker A, Sabin C, Young J, Dorrucci M, Chêne G, Mussini C, Porter K, Bucher HC; CASCADE Collaboration Members.

PLoS Med. 2010 Feb 23;7(2):e1000239. doi: 10.1371/journal.pmed.1000239.

PMID:
20186270
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk